Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
SC 13G/A	Feb 11, 2022	PROTALIX BIOTHERAPEUTICS, INC.
SC 13G/A	Jan 31, 2022	SC 13G/A
8-K	Dec 22, 2021	8-K
8-K	Nov 24, 2021	8-K
10-Q	Nov 15, 2021	10-Q
8-K	Nov 15, 2021	8-K
DEFA14A	Nov 9, 2021	DEFA14A
8-K	Oct 12, 2021	8-K
DEF 14A	Sep 30, 2021	DEF 14A
PRE 14A	Sep 17, 2021	PRE 14A
8-K	Aug 26, 2021	8-K
10-Q	Aug 16, 2021	10-Q
8-K	Aug 16, 2021	8-K
8-K	Aug 13, 2021	8-K
SC 13G/A	Jul 30, 2021	SCHEDULE 13G/A
8-K	Jul 7, 2021	8-K
424B5	Jul 2, 2021	424B5
8-K	Jul 2, 2021	FORM 8-K
424B5	Jul 2, 2021	424B5
8-K	Jun 30, 2021	8-K
SC 13G/A	Jun 15, 2021	SC 13G/A
DEF 14A	Jun 4, 2021	DEF 14A
4	Jun 3, 2021	OWNERSHIP DOCUMENT
8-K	Jun 2, 2021	8-K
10-Q	May 14, 2021	10-Q

← Newer Page 8 of 38 · 935 filings Older →